Clinical trial · Interventional
Auricular Acupressure : Improves Oxaliplatin-induced Peripheral Neuropathy
Auricular Acupressure Improves Oxaliplatin-induced Peripheral Neuropathy and Quality of Life
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Oxaliplatin-induced peripheral neuropathy (OIPN) is a common adverse effect that becomes worse as the drug dose accumulation impacts cancer patients' daily activities and quality of life.The result of this study will determine the immediate effects of the 8-week auricular acupuncture intervention on alleviating the participants' OIPN symptoms and enhancing their quality of life. This study will continue to evaluate the carry-over effects of auricular acupuncture after the chemotherapy course ends.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapy | — | UNRESOLVED | — |
| Oxaliplatin-induced Peripheral Neuropathy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| auricular acupressure | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Experimental group
- description
- The experimental group will receive acupressure on six auricular points.
- interventionNames
- Other: auricular acupressure
- type
- NO_INTERVENTION
- label
- Control group
- description
- The control group will receive no intervention.
Primary outcomes (4)
- measure
- National Cancer Institute Common Terminology Criteria for Adverse Events v5.0[NCI-CTCAE v5.0]
- timeFrame
- This assessment tool is used at baseline, change from baseline after 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, and one month followed by completing the chemotherapy course.
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Colorectal cancer patients who are above the age of 20 years * Have experiencing Oxaliplatin induced peripheral neuropathy * Must be able to communicate * Willing to fill out the inform consent Exclusion Criteria: * Symptoms of peripheral neuropathy caused by diabetes mellitus * Symptoms of peripheral neuropathy caused by genetic disease * Symptoms of peripheral neuropathy caused by spinal cord injury * Symptoms of peripheral neuropathy caused by alcoholism * With wounds on ears * Allergy to latex (the tapes for the auricular acupressure include latex)
References
Publications (0)
Data not yet available